{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T00:39:11Z","timestamp":1792370351149,"version":"4.4.0"},"reference-count":37,"publisher":"The Endocrine Society","issue":"1","license":[{"start":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T00:00:00Z","timestamp":1749254400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,18]]},"abstract":"Abstract<\/jats:title>\n \n Context<\/jats:title>\n There are currently 2 classes of thyroid-stimulating hormone receptor (TSHR) antibody assays, namely TSHR antibody (TRAb) assays and thyroid-stimulating immunoglobulin (TSI) assays. Clinical guidelines do not currently specify appropriate use of TSHR autoantibody tests in the diagnosis of hyperthyroidism, which may result in paired orders for both tests with the possibility of discordant results and excessive costs.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n This work aimed to evaluate the clinical and analytical redundancy of paired TSHR autoantibody testing\u2014specifically TRAb and TSI assays\u2014in the diagnosis of autoimmune-mediated hyperthyroidism, by analyzing the frequency of paired orders, assay concordance, and clinical correlation across a large cohort of patient encounters.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n Over 189 000 patient encounters with TRAb and TSI bioassay (TSI-BA) or TSI bridge immunoassay (TSI-Br) test orders were examined to assess the frequency of paired orders and qualitative agreement of TRAB\/TSI. A chart review was performed on a subset of patients for clinical correlation. Lastly, a cost analysis was performed to estimate the financial burden of unnecessary paired testing.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n TRAb and TSI were co-ordered on the same encounter in 14.3% of TRAb\/TSI-BA orders and 17.4% of TRAb\/TSI-Br orders. Qualitative comparison showed discordance in 12.5% (1590) of TRAb and TSI-BA paired orders and 6.6% (1149) of TRAb and TSI-Br paired orders. Based on patient free thyroxine and TSH concentrations and disease status, the TSI assays aligned better with hyperthyroidism and confirmed Graves disease diagnoses. Paired orders resulted in a 31% to 325% increase in potentially unnecessary testing costs.<\/jats:p>\n <\/jats:sec>\n \n Conclusion<\/jats:title>\n We observed good clinical and analytical agreement between TRAb and TSI assays, suggesting that paired orders for TRAb and TSI are redundant in the assessment of autoimmune-mediated hyperthyroidism. Use of a single test to assess TRAb would be appropriate in most scenarios and may lead to considerable savings of health care dollars.<\/jats:p>\n <\/jats:sec>","DOI":"10.1210\/clinem\/dgaf330","type":"journal-article","created":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T07:45:39Z","timestamp":1749282339000},"page":"e92-e99","source":"Crossref","is-referenced-by-count":7,"title":["TSH Receptor Antibody Test Utilization Patterns From a National Reference Laboratory: TRAb, TSI, or Both?"],"prefix":"10.1210","volume":"111","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4622-2923","authenticated-orcid":false,"given":"Heather A","family":"Nelson","sequence":"first","affiliation":[{"name":"Department of Pathology, University of Utah Health , Salt Lake City, UT 84108 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Doyle","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Utah Health , Salt Lake City, UT 84108 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joely A","family":"Straseski","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Utah Health , Salt Lake City, UT 84108 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2025,6,7]]},"reference":[{"key":"2025121807433753800_dgaf330-B1","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.cca.2013.09.021","article-title":"Utilization management in the clinical laboratory: an introduction and overview of the literature","volume":"427","author":"Huck","year":"2014","journal-title":"Clin Chim Acta"},{"issue":"6","key":"2025121807433753800_dgaf330-B2","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1309\/AJCPX1HIEM4KLGNU","article-title":"Do we now know what inappropriate laboratory utilization is? An expanded systematic review of laboratory clinical audits","volume":"141","author":"Hauser","year":"2014","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"2025121807433753800_dgaf330-B3","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1373\/jalm.2016.020792","article-title":"The struggle is real: lab leaders discuss utilization challenges during a 2-day summit","volume":"1","author":"Brown","year":"2016","journal-title":"J Appl Lab Med"},{"issue":"1","key":"2025121807433753800_dgaf330-B4","first-page":"15","article-title":"Towards better test utilization\u2014strategies to improve physician ordering and their impact on patient outcomes","volume":"26","author":"Freedman","year":"2015","journal-title":"EJIFCC"},{"issue":"3","key":"2025121807433753800_dgaf330-B5","first-page":"146","article-title":"Are guidelines guiding us on how to utilize laboratory tests?","volume":"26","author":"Horvath","year":"2015","journal-title":"EJIFCC"},{"issue":"10","key":"2025121807433753800_dgaf330-B6","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1089\/thy.2016.0229","article-title":"2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis","volume":"26","author":"Ross","year":"2016","journal-title":"Thyroid"},{"issue":"5","key":"2025121807433753800_dgaf330-B7","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/cen.13327","article-title":"Measuring TSH receptor antibody to influence treatment choices in Graves\u2019 disease","volume":"86","author":"Hesarghatta Shyamasunder","year":"2017","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"2025121807433753800_dgaf330-B8","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.autrev.2009.03.012","article-title":"TSH receptor autoantibodies","volume":"9","author":"Michalek","year":"2009","journal-title":"Autoimmun Rev"},{"issue":"10","key":"2025121807433753800_dgaf330-B9","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1089\/thy.2004.14.830","article-title":"A new assay for thyrotropin receptor autoantibodies","volume":"14","author":"Rees Smith","year":"2004","journal-title":"Thyroid"},{"issue":"2","key":"2025121807433753800_dgaf330-B10","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.autrev.2010.08.018","article-title":"Bioassays for TSH-receptor autoantibodies: an update","volume":"10","author":"Lytton","year":"2010","journal-title":"Autoimmun Rev"},{"issue":"2","key":"2025121807433753800_dgaf330-B11","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1365-2249.2012.04648.x","article-title":"Measurement of thyroid stimulating immunoglobulins using a novel thyroid stimulating hormone receptor\u2013guanine nucleotide-binding protein, (GNAS) fusion bioassay","volume":"170","author":"Pierce","year":"2012","journal-title":"Clin Exp Immunol"},{"issue":"12","key":"2025121807433753800_dgaf330-B12","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1055\/s-0035-1554662","article-title":"Bridge technology with TSH receptor chimera for sensitive direct detection of TSH receptor antibodies causing graves\u2019 disease: analytical and clinical evaluation","volume":"47","author":"Frank","year":"2015","journal-title":"Horm Metab Res"},{"issue":"4","key":"2025121807433753800_dgaf330-B13","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1055\/a-2021-0596","article-title":"Comparison between thyroid stimulating immunoglobulin and TSH-receptor antibodies in the management of Graves\u2019 orbitopathy","volume":"131","author":"Khamisi","year":"2023","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"8","key":"2025121807433753800_dgaf330-B14","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1038\/eye.2013.120","article-title":"Relevance of TSH-receptor antibody levels in predicting disease course in Graves\u2019 orbitopathy: comparison of the third-generation TBII assay and Mc4-TSI bioassay","volume":"27","author":"Jang","year":"2013","journal-title":"Eye"},{"issue":"1","key":"2025121807433753800_dgaf330-B15","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12902-019-0363-6","article-title":"Comparison of five TSH-receptor antibody assays in Graves\u2019 disease: results from an observational pilot study","volume":"19","author":"Struja","year":"2019","journal-title":"BMC Endocr Disord"},{"issue":"3","key":"2025121807433753800_dgaf330-B16","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1373\/jalm.2017.024067","article-title":"Analytical and clinical validation of two commercially available immunoassays used in the detection of TSHR antibodies","volume":"2","author":"Kemble","year":"2017","journal-title":"J Appl Lab Med"},{"issue":"12","key":"2025121807433753800_dgaf330-B17","doi-asserted-by":"crossref","first-page":"e22468","DOI":"10.1016\/j.heliyon.2023.e22468","article-title":"Comparison of two different TSH-receptor antibody assays: a clinical practice study","volume":"9","author":"Van Balkum","year":"2023","journal-title":"Heliyon"},{"issue":"3","key":"2025121807433753800_dgaf330-B18","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1089\/thy.2016.0457","article-title":"2017 guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and the postpartum","volume":"27","author":"Alexander","year":"2017","journal-title":"Thyroid"},{"issue":"8","key":"2025121807433753800_dgaf330-B19","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1210\/jc.2011-2803","article-title":"Management of thyroid dysfunction during pregnancy and postpartum: an endocrine society clinical practice guideline","volume":"97","author":"De Groot","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"2025121807433753800_dgaf330-B20"},{"issue":"1-2","key":"2025121807433753800_dgaf330-B21","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.cca.2008.11.025","article-title":"Technical evaluation of the first fully automated assay for the detection of TSH receptor autoantibodies","volume":"401","author":"Hermsen","year":"2009","journal-title":"Clin Chim Acta"},{"key":"2025121807433753800_dgaf330-B22"},{"key":"2025121807433753800_dgaf330-B23"},{"key":"2025121807433753800_dgaf330-B24"},{"key":"2025121807433753800_dgaf330-B25","author":"Nelson"},{"key":"2025121807433753800_dgaf330-B26","doi-asserted-by":"crossref","first-page":"1487490","DOI":"10.3389\/fendo.2024.1487490","article-title":"Comparison between thyroid stimulating immunoglobulin and TSH-receptor antibodies in the diagnosis and management of graves\u2019 disease","volume":"15","author":"Yao","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"9","key":"2025121807433753800_dgaf330-B27","doi-asserted-by":"crossref","first-page":"e3002","DOI":"10.1210\/clinem\/dgae892","article-title":"Significance of thyroid stimulating immunoglobulin and thyrotropin receptor antibody in Graves\u2019 disease","volume":"110","author":"Peng","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2025121807433753800_dgaf330-B28","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s12902-022-01114-3","article-title":"Clinical evaluation of an automated TSI bridge immunoassay in the diagnosis of Graves\u2019 disease and its relationship to the degree of hyperthyroidism","volume":"22","author":"Liu","year":"2022","journal-title":"BMC Endocr Disord"},{"key":"2025121807433753800_dgaf330-B29","doi-asserted-by":"crossref","first-page":"110938","DOI":"10.1016\/j.clinbiochem.2025.110938","article-title":"Performance of the Siemens\u2019 thyroid stimulating immunoglobulin assay in the diagnosis of hyperthyroidism: prospective cohort study","volume":"137","author":"Kline","year":"2025","journal-title":"Clin Biochem"},{"issue":"9","key":"2025121807433753800_dgaf330-B30","first-page":"3283","article-title":"Effect of methimazole with or without exogenous L-thyroxine on serum concentrations of thyrotropin (TSH) receptor antibodies in patients with Graves\u2019 disease","volume":"81","author":"Rittmaster","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2025121807433753800_dgaf330-B31","doi-asserted-by":"crossref","first-page":"204201882110449","DOI":"10.1177\/20420188211044943","article-title":"The prognostic value of thyroid-stimulating immunoglobulin in the management of Graves\u2019 disease","volume":"12","author":"Zhou","year":"2021","journal-title":"Ther Adv Endocrinol Metab"},{"issue":"3","key":"2025121807433753800_dgaf330-B32","doi-asserted-by":"crossref","first-page":"bvaf016","DOI":"10.1210\/jendso\/bvaf016","article-title":"Predictive performance of 2 immunoassays in patients with Graves disease undergoing radioiodine therapy: prospective study","volume":"9","author":"de Souza","year":"2025","journal-title":"J Endocr Soc"},{"issue":"5","key":"2025121807433753800_dgaf330-B33","first-page":"363","article-title":"Hyperthyroidism: diagnosis and treatment","volume":"93","author":"Kravets","year":"2016","journal-title":"Am Fam Physician"},{"issue":"2","key":"2025121807433753800_dgaf330-B34","doi-asserted-by":"crossref","first-page":"110","DOI":"10.5603\/NMR.2015.0026","article-title":"Diagnosis and treatment of Graves\u2019 disease with particular emphasis on appropriate techniques in nuclear medicine. General state of knowledge","volume":"18","author":"Prasek","year":"2015","journal-title":"Nucl Med Rev Cent East Eur"},{"key":"2025121807433753800_dgaf330-B35","author":"Centers for Medicare & Medicaid Services"},{"key":"2025121807433753800_dgaf330-B36"},{"issue":"12","key":"2025121807433753800_dgaf330-B37","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.2105\/AJPH.2020.305865","article-title":"Excess medical care spending: the categories, magnitude, and opportunity costs of wasteful spending in the United States","volume":"110","author":"Speer","year":"2020","journal-title":"Am J Public Health"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgaf330\/63450021\/dgaf330.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/111\/1\/e92\/63450021\/dgaf330.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/111\/1\/e92\/63450021\/dgaf330.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T12:45:12Z","timestamp":1766061912000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/111\/1\/e92\/8158271"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,7]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,6,7]]},"published-print":{"date-parts":[[2025,12,18]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgaf330","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,1]]},"published":{"date-parts":[[2025,6,7]]}}}